Business
Inside information: Bioretec Ltd's Board of Directors is assessing a potential rights issue in the near future
The Board of Directors of Bioretec Ltd ("Bioretec" or the "Company") is assessing a potential rights issue based on the shareholders' pre-emptive subscription right (the "Offering") in the near future. The targeted gross proceeds to be raised through the Offering would preliminarily be approximately EUR 15 million.
About this update from Bioretec Ltd.
[{"type":"text","content":"Bioretec Ltd Inside information 13 February 2026 at 9.31 a.m. EET","length":65,"tagName":"p"},{"type":"text","content":"NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.","length":351,"tagName":"p"},{"type":"text","content":"TAMPERE, Finland, Feb. 13, 2026 /PRNewswire/ -- The Board of Directors of Bioretec Ltd ("Bioretec" or the "Company") is assessing a potential rights issue based on the shareholders' pre-emptive subscription right (the "Offering") in the near future. The targeted gross proceeds to be raised through the Offering would preliminarily be approximately EUR 15 million.","length":403,"tagName":"p"},{"type":"text","content":"Bioretec announced its updated strategy and financial targets in a company release on 16 December 2025. The potential Offering would strengthen the Company's capital base and financing resources supporting the execution of the new strategy.","length":244,"tagName":"p"},{"type":"text","content":"The execution of the potential Offering would be subject to, among other things, a share issue authorisation granted by a general meeting of shareholders of Bioretec and a resolution by the Board of Directors of Bioretec regarding the Offering. The Board of Directors of Bioretec has not made any final decisions concerning the execution of the Offering and emphasizes that the execution of the potential Offering is not yet certain.","length":433,"tagName":"p"},{"type":"text","content":"DNB Carnegie Investment Bank AB, Finland Branch has been mandated to investigate the structure and terms for a potential Offering.","length":130,"tagName":"p"},{"type":"text","content":"Further enquiries","length":17,"tagName":"p"},{"type":"text","content":"Sarah van Hellenberg Hubar-Fisher, CEO, +31 6 1544 8736Tuukka Paavola, CFO, +358 50 386 0013","length":93,"tagName":"p"},{"type":"text","content":"Certified adviser","length":17,"tagName":"p"},{"type":"text","content":"Nordic Certified Adviser AB, +46 70 551 67 29","length":45,"tagName":"p"},{"type":"text","content":"Information about ...